The growth delay was potentially induced by a combined effect of anti-PD1 treatment on tumor cell death and tumor cell proliferation, as shown by the trends observed with IHC of KI-67 and caspase-3, respectively, assessed after two cycles of immunotherapy (Figure 1D,E). Here, PDCD1 is linked to neoplasm.